Immune-Activating Mechanisms of Replicase-Based DNA and RNA Vaccines and Their Role in Immune-Apoptosis
Author:
Leitner Wolfgang W.
Publisher
Springer Vienna
Reference52 articles.
1. Alexander-Miller MA, Leggatt GR, Berzofsky JA (1996) Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc Natl Acad Sci USA 93(9):4102–4107 2. Baccala R, Gonzalez-Quintial R, Lawson BR, Stern ME, Kono DH, Beutler B, Theofilopoulos AN (2009) Sensors of the innate immune system: their mode of action. Nat Rev Rheumatol 5(8):448–456 3. Barnett SW, Burke B, Sun Y, Kan E, Legg H, Lian Y, Bost K, Zhou F, Goodsell A, Zur Megede J, Polo J, Donnelly J, Ulmer J, Otten GR, Miller CJ, Vajdy M, Srivastava IK (2010) Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant. J Virol 84(12):5975–5985 4. Bergen MJ, Pan CH, Greer CE, Legg HS, Polo JM, Griffin DE (2010) Comparison of the immune responses induced by chimeric alphavirus-vectored and formalin-inactivated alum-precipitated measles vaccines in mice. PLoS ONE 5(4):e10297 5. Bergmann-Leitner ES, Leitner WW, Duncan EH, Savranskaya T, Angov E (2009) Molecular adjuvants for malaria DNA vaccines based on the modulation of host-cell apoptosis. Vaccine 27(41):5700–5708
|
|